136 related articles for article (PubMed ID: 3954328)
1. Tumor inhibition by titanocene complexes: activity against sarcoma 180.
Köpf-Maier P; Preiss F; Marx T; Klapötke T; Köpf H
Anticancer Res; 1986; 6(1):33-7. PubMed ID: 3954328
[TBL] [Abstract][Full Text] [Related]
2. Tumor inhibition by titanocene complexes. Activity against B16 melanoma and colon 38 carcinoma.
Köpf-Maier P; Köpf H
Arzneimittelforschung; 1987 May; 37(5):532-4. PubMed ID: 3619974
[TBL] [Abstract][Full Text] [Related]
3. Tumor inhibition by ferricenium complexes. Activity against some solid experimental tumors.
Köpf-Maier P; Klapötke T
Arzneimittelforschung; 1989 Mar; 39(3):369-71. PubMed ID: 2757661
[TBL] [Abstract][Full Text] [Related]
4. Antitumor metallocenes: new developments and toxicologic features.
Köpf-Maier P; Köpf H
Anticancer Res; 1986; 6(2):227-33. PubMed ID: 3707060
[TBL] [Abstract][Full Text] [Related]
5. Activity of titanocene dihalides against a human colon carcinoma heterotransplanted to athymic mice.
Köpf-Maier P; Moormann A; Köpf H
Eur J Cancer Clin Oncol; 1985 Jul; 21(7):853-7. PubMed ID: 4043173
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma.
Köpf-Maier P
Anticancer Res; 1999; 19(1A):493-504. PubMed ID: 10226588
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of an ionic titanocene tetrachloroferrate derivative against some solid experimental tumors.
Köpf-Maier P; Klapötke T
Arzneimittelforschung; 1989 Apr; 39(4):488-90. PubMed ID: 2751735
[TBL] [Abstract][Full Text] [Related]
8. Ionic titanocene complexes: a new type of antitumor agent.
Köpf-Maier P; Neuse E; Klapötke T; Köpf H
Cancer Chemother Pharmacol; 1989; 24(1):23-7. PubMed ID: 2720888
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of Titanocene Y against freshly explanted human breast tumor cells and in xenografted MCF-7 tumors in mice.
Beckhove P; Oberschmidt O; Hanauske AR; Pampillón C; Schirrmacher V; Sweeney NJ; Strohfeldt K; Tacke M
Anticancer Drugs; 2007 Mar; 18(3):311-5. PubMed ID: 17264764
[TBL] [Abstract][Full Text] [Related]
10. [Synthesis and antitumor activity of beta-diketonato complexes of titanium].
Zhao YW; Yuan HL
Yao Xue Xue Bao; 1993; 28(5):397-9. PubMed ID: 8237388
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of diethoxy-(1-phenyl-1,3-butanedionato) titanium (IV) in human tumour xenografts.
Mattern J; Keppler B; Volm M
Arzneimittelforschung; 1984; 34(10):1289-90. PubMed ID: 6549134
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato) titanium(IV) compounds against Walker 256 carcinosarcoma. A new class of antineoplastic agents.
Keller HJ; Keppler B; Schmähl D
Arzneimittelforschung; 1982; 32(8):806-7. PubMed ID: 6890355
[TBL] [Abstract][Full Text] [Related]
13. Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.
Valadares MC; Ramos AL; Rehmann FJ; Sweeney NJ; Strohfeldt K; Tacke M; Queiroz ML
Eur J Pharmacol; 2006 Mar; 534(1-3):264-70. PubMed ID: 16513106
[TBL] [Abstract][Full Text] [Related]
14. Preclinical evaluation of dichlorobis(1-phenylbutane-1,3-dionato)titanium (IV) and budotitane. Two representatives of the new class of antitumor-active bis-beta-diketonato metal complexes.
Keppler BK; Schmähl D
Arzneimittelforschung; 1986 Dec; 36(12):1822-8. PubMed ID: 3566844
[TBL] [Abstract][Full Text] [Related]
15. Tumor inhibition by metallocenes: antitumor activity of titanocene dihalides (C5H5)2TiX2 (X=F, Cl, Br, I, NCS) and their application in buffered solutions as a method for suppressing drug-induced side effects.
Köpf-Maier P; Hesse B; Voigtländer R; Köpf H
J Cancer Res Clin Oncol; 1980; 97(1):31-9. PubMed ID: 7400205
[TBL] [Abstract][Full Text] [Related]
16. [Histomorphologic changes in Jensen sarcoma following radiotherapy, titanocene dichloride treatment and combination therapy].
Uhl J; Langrock K; Krieghoff B; Hambsch K
Radiobiol Radiother (Berl); 1987; 28(1):51-7. PubMed ID: 3588859
[No Abstract] [Full Text] [Related]
17. Tumor inhibition by titanocene complexes: influence upon two xenografted human lung carcinomas.
Köpf-Maier P
J Cancer Res Clin Oncol; 1987; 113(4):342-8. PubMed ID: 3036884
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of titanocene amino acid complexes.
Köpf-Maier P; Tornieporth-Oetting IC
Biometals; 1996 Jul; 9(3):267-71. PubMed ID: 8696077
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of phenyl substituted dihalogenobis (1-phenyl-1,3-butanedionato)titanium (IV) compounds.
Keppler BK; Diez A; Seifried V
Arzneimittelforschung; 1985; 35(12):1832-6. PubMed ID: 4096739
[TBL] [Abstract][Full Text] [Related]
20. The ruthenium complex cis-(dichloro)tetraammineruthenium(III) chloride presents selective cytotoxicity against murine B cell lymphoma (A-20), murine ascitic sarcoma 180 (S-180), human breast adenocarcinoma (SK-BR-3), and human T cell leukemia (Jurkat) tumor cell lines.
Silveira-Lacerda Ede P; Vilanova-Costa CA; Hamaguchi A; Pavanin LA; Goulart LR; Homsi-Brandenburgo MI; Dos Santos WB; Soares AM; Nomizo A
Biol Trace Elem Res; 2010 Jun; 135(1-3):98-111. PubMed ID: 19727575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
